From PR Newswire - Sep 24, 2007
WILMINGTON, Del., and DALLAS, September 24, 2007 
/PRNewswire-FirstCall/ -- Depression is one of the leading causes of 
disability in the United States, affecting approximately 14.8 million 
adults or about 6.7 percent of the population age 18 and older in a 
given year. To address this growing problem, AstraZeneca today 
announced that it will collaborate with the University of Texas 
Southwestern Medical Center to accelerate scientific discovery and 
therapeutic advancement for depression.


"People Who experience mood swings, fear, voices and visions"